Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Twist Bioscience Expects Q4 2024 Revenues Of $82M-$83M Versus Prior Guidance Of $77M-$80M And Consensus Of $79.602M

Author: Benzinga Newsdesk | August 02, 2024 07:37am

For the fourth quarter of fiscal year 2024, Twist provided the following financial guidance:

Total revenue of approximately $82 million to $83 million compared to the previous estimate of $77 million to $80 million
Gross margin of approximately 44% compared to the previous estimate of 43-44%
Adjusted EBITDA loss of $20 million

Posted In: TWST